Probable Catastrophic Antiphospholipid Syndrome in a Patient with Immune Thrombocytopenia Treated with a Thrombopoietin Receptor Agonist

Hamostaseologie 2025; 45(S 01): S92
DOI: 10.1055/s-0044-1801688

Abstracts

Topics

T-10 Platelets – Disorders of platelet function and numbers

Authors

L E Kausche

¹Kepler University Hospital, Medical Department of Hematology and Oncology, Linz, Austria

²Johannes Kepler University Linz, Medical Department of Hematology and Oncology, Linz, Austria
J Tomasits

¹Kepler University Hospital, Medical Department of Hematology and Oncology, Linz, Austria
A Stefan

¹Kepler University Hospital, Medical Department of Hematology and Oncology, Linz, Austria
H Diesenberger

⁴Kepler University Hospital, Department of Internal Medicine 2 (Gastroenterology and Hepatology, Endocrinology and Metabolism, Nephrology, Rheumatology), Linz, Austria

⁵Johannes Kepler University Linz, Faculty of Medicine, Linz, Austria
A R Moschen

⁴Kepler University Hospital, Department of Internal Medicine 2 (Gastroenterology and Hepatology, Endocrinology and Metabolism, Nephrology, Rheumatology), Linz, Austria

⁵Johannes Kepler University Linz, Faculty of Medicine, Linz, Austria
I Pabinger

¹Kepler University Hospital, Medical Department of Hematology and Oncology, Linz, Austria

³Medical University of Vienna, Division of Hematology and Hemostaseology, Department of Medicine I, Vienna, Austria
C A Schmitt

¹Kepler University Hospital, Medical Department of Hematology and Oncology, Linz, Austria

²Johannes Kepler University Linz, Medical Department of Hematology and Oncology, Linz, Austria

References
1 Tjepkema M, Amini S, Scipperus M. 2022. 'Risk of thrombosis with thrombopoietin receptor agonists for ITP patients: A systematic review and meta-analysis', Crit Rev Oncol Hematol. 171. 103581 the Netherlands: CRC Press;
2 Tomassello R. et al. 2022. 'Immune Thrombocytopenia in Antiphospholipid Syndrome: Is It Primary or Secondary?', Biomedicines. 9. 09 1170 Swizerland: MDPI AG;
3 Oo Z, Mancar K, Chin Wang J. 2022. 'Eltrombopag-Induced Thrombocytosis and Thrombosis in Patients With Antiphospholipid Syndrome and Immune Thrombocytopenic Purpura', J Investig Med High Impact Case Rep. 10. 1-4 United States: Sage on behalf of: American Federation for Medical Research;
4 Van de Vondel S. et al. 2023. 'Catastrophic antiphospholipid syndrome in an immune thrombocytopenia patient treated with avatrombopag', Res Pract Thromb Haemost. 7. 03 100125 United States: John Wiley & Sons, Inc;
5 Garra W. et al. 2023. 'Catastrophic antiphospholipid syndrome in lupus-associated immune thrombocytopenia treated with eltrombopag A case series and literature review', Medicine. 102. 06 e32949 United States: Lippincott Williams & Wilkins;
6 Nies JF. et al. 2024. '[Acute renal injury in immune thrombocytopenia and antiphospholipid syndrome]', Die Nephrologie. 19. 110-112 Germany: Springer Medizin Verlag GmbH;